Biora Therapeutics, Inc.
Biora Therapeutics, Inc. (BIOR) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
bior · pe ratio · data through Dec 31, 2023
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Biora Therapeutics, Inc. (BIOR) measures how much investors pay for each dollar of the company's trailing earnings. BIOR's current PE ratio of N/A is calculated by dividing its stock price of $0.22 by its TTM earnings per share of -$78.69.
Source: FMP · /ratios-ttm · /analyst-estimates · 2023-12-31
PE Ratio History
2018 – 2023 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Biora Therapeutics, Inc.You BIOR | $1M | N/A | — | -$78.69 |
 Bio-Path Holdings, Inc. BPTH | $0M | N/A | — | -$1.10 |
 Chia Tai Enterprises International Limited CAIHF | $1M | 2.21x | -15.2% | $0.13 |
 Endexx Corporation EDXC | $0M | N/A | — | -$0.01 |
 Epigenomics AG EPGNF | $1M | N/A | — | -$0.36 |
 Evofem Biosciences, Inc. EVFM | $1M | 3.00x | +15.2% | $0.00 |
 Halberd Corporation HALB | $1M | N/A | — | -$0.00 |
Industry Average 2 peers with valid PE | — | 2.61x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2023-12-31Latest FY2023 | — | $-78.69 | — | |
2022-12-31 FY2022 | — | $-49.98 | — | |
2021-12-31 FY2021 | — | $-464.15 | — | |
2020-12-31 FY2020 | — | $-863.01 | — | |
2019-12-31 FY2019 | — | $-801.69 | — | |
2018-12-31 FY2018 | — | $-1197.14 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Biora Therapeutics, Inc. (BIOR) measures how much investors pay for each dollar of the company's trailing earnings. BIOR's current PE ratio of N/A is calculated by dividing its stock price of $0.22 by its TTM earnings per share of -$78.69.
Frequently asked questions
BIOR pe ratio · 6 questionsBIOR's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.22 and TTM EPS of -$78.69. Data sourced from Financial Modeling Prep via BIOR's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Biora Therapeutics, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09